Company intelligence
Medix Biochemica
Independent, international, and industry-leading critical raw materials partner to the global IVD community
About Medix Biochemica
With Finnish roots and rapidly growing global branches, Medix Biochemica is a leading supplier of critical raw materials to the in vitro diagnostics (IVD) industry worldwide. We develop, produce and supply high-quality antibodies, antigens, and other critical raw material products to our IVD partners all around the world, enabling the delivery of accurate IVD tests to billions of patients worldwide. Our expertise covers everything from immuno- and molecular diagnostic reagents to biospecimens and custom services. With the most comprehensive raw material portfolio in the IVD world, and a team made up of the best minds in the business, we’re ready to shorten our customers’ time to market and build quality into every one of their tests. Across disciplines and disease areas, whatever you need, chances are we IVDo that. Visit our website today⬇️
Verified activity
Signals from Medix Biochemica
3 published signals
Capital & Finance
Medix Biochemica committed $5 million to expand its recombinant antigen and cell culture capabilities across its facilities in Finland and the US.
Reported by Medix Biochemica
Products & Services
Medix Biochemica developed an Anti-Xylazine monoclonal antibody R14501 and Xylazine-BSA Antigen for competitive immunoassay development.
Reported by Medix Biochemica
People
Medix Biochemica welcomed Chris Rapcan as Vice President, Quality Controls.
Reported by Medix Biochemica